Early Intervention in Multiple Myeloma—Exploring New Frontiers
Year: 2018
Type: article
Abstract: The progress that has been made in myeloma during the past decade has been remarkable, and paralleled by few other cancers, if any. This has come through a combination of better understanding of the disease biology, introduction of new drug classes, development of rational and highly effective combinations, extended duration of therapy, and better supportive care. However, we are still far from being able to label myeloma as a curable disease given the inability to predict who, if any, will be able to have a normal life expectancy after a diagnosis of myeloma. We clearly need a different approach to achieve this elusive goal. What might that be?
Author: Shaji K Kumar
Institution: Mayo Clinic
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W2803081117